Raia Drogasil (BSP:RADL3) Marketable Securities: R$96 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:RADL3 Raia Drogasil SA BSP:RADL3
91 GF Score
Price R$17.98
GF Value R$30.05
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Raia Drogasil Marketable Securities?

Raia Drogasil BSP:RADL3 -1.15% 91 Marketable Securities is R$96 Mil as of Mar. 2026. GuruFocus rates BSP:RADL3 with a GF Score™ of 91/100 and a GF Value™ of R$30.05 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Raia Drogasil's Marketable Securities for the quarter that ended in Mar. 2026 was R$96 Mil.

Raia Drogasil's annual Marketable Securities increased from Dec. 2023 (R$0 Mil) to Dec. 2024 (R$16 Mil) and increased from Dec. 2024 (R$16 Mil) to Dec. 2025 (R$19 Mil).

Raia Drogasil  (BSP:RADL3) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Raia Drogasil Marketable Securities Related Terms

Raia Drogasil Marketable Securities Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil Marketable Securities Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 15.71 19.12

Raia Drogasil Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.80 78.28 102.05 19.12 95.93
BSP:RADL3
91GF Score
Raia Drogasil SA BSP:RADL3
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of R$96 Mil mean?
Raia Drogasil (BSP:RADL3) has a Marketable Securities of R$96 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Raia Drogasil and its competitors.
Is Raia Drogasil's Marketable Securities too high?
Raia Drogasil's current Marketable Securities is R$96 Mil. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Marketable Securities compare to competitors?
Raia Drogasil's Marketable Securities of R$96 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Raia Drogasil and its competitors. Raia Drogasil's current Marketable Securities is R$96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$30.05, compared to a current price of R$17.98 — trading 40.2% below its estimated fair value. The current Marketable Securities is R$96 Mil. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Marketable Securities is R$96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$17.98 is trading 40.2% below its estimated GF Value™ of R$30.05. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for BSP:RADL3:

  • Marketable Securities: R$96 Mil
  • GF Value™: R$30.05 vs. price of R$17.98 (40.2% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score

Get the complete analysis for BSP:RADL3

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$17.98
Price
R$30.05
GF Value